Sinobiopharma Inc.’s (SNBP.OB) Flagship Product Covered by China’s Basic Medical Insurance
Sinobiopharma Inc. is a fully integrated specialty biopharmaceutical company in one of the world's fastest growing pharmaceutical markets – China. Known as Dong Ying (Jiangsu) Pharmaceutical Company Ltd. in China, the company's current therapeutic focus is on cardiovascular drugs and anesthesia-assisted agents. The company announced today that the Chinese government has approved the company's flagship product, Ku Tai (Cisatracurium Besylate) for coverage under National Basic Medical Insurance, Employment Injury Insurance and Maternity Insurance. Sinobiopharma's flagship product, which has been on the market since 2006, had not been covered by any medical insurance before the Chinese government granted approval for its…